Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LF-PB (octreotide extended release) for postoperative lymphorrhea after axillary dissection in breast cancer
2012-000114-10Phase 2Completed
- Sponsor
- Chemi S.p.A.
- Start
- Oct 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of octreotide in Lymphorrhea (4 arms), sponsored by Chemi S.p.A. Primary endpoint: Duration of lymphorrhea while drain is in place. Started Oct 2012; status: completed.
02
Drugs
octreotide
03
Conditions
Lymphorrhea
Beyond the preview
Go deeper on 2012-000114-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000114-10.